Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 294, pseudogene (RN7SL294P)

Target
RN7SL294P
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RN7SL294P (RNA, 7SL, cytoplasmic 294, pseudogene) is classified as a pseudogene of the 7SL RNA family. 7SL RNA itself is the RNA component of the signal recognition particle (SRP), which is essential for protein translocation across the endoplasmic reticulum, but RN7SL294P is not a functional gene; it is a non-coding, transcriptionally inactive copy derived from the retrotransposition or duplication of 7SL RNA[1][2][3][6]. The human genome contains numerous 7SL-like sequences, but only a few are expressed as functional 7SL RNA; most, including RN7SL294P, are truncated, structurally variant pseudogenes dispersed throughout the genome[2][3][6]. These pseudogenes do not code for active SRP RNA and are not known to have any direct biological function, disease association, or relevance as therapeutic targets[1][2][3][6]. Pseudogenes like RN7SL294P may contribute to genomic diversity or evolution but do not encode proteins or active regulatory elements under normal physiological circumstances[2][3][6]. Key Points: - RN7SL294P is not a therapeutic target; it is a pseudogene and not functionally active in cellular processes[1][2][3][6]. - There is no evidence for its involvement in disease, biomarker status, or drug interactions[1][2][3][6]. - The name and abbreviation are correct, with no indication of error or spurious entry[1].

Other names
RN7SL294P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 294, pseudogene (RN7SL294P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 294, pseudogene (RN7SL294P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call